Covid19 pandemic has highlighted the lack of manufacturing medical products capacity in Africa and dependence on international imports and donations.
To address the challenge of an equitable access to Covid19 vaccines, the African Union has launched several initiatives and announced the goal to produce locally 60% of the Africa’s vaccine requirements by 2040. At this momentum, operationalization of the African Medicines Agency will also be a game changer that will contribute to ensure a sustainable development of local manufacturing.
The AFD Group, as part of a larger Team Europe effort, is contributing to this AU ambition to build reliant pharmaceutical systems. This includes supporting manufacturing capacities as well as human capital skills set and strengthening the regulatory framework.